All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Bookmark this article
The Lymphoma Hub was delighted to host an interview with Ulrich Jäger, Medical University of Vienna, Vienna, AT. We asked, What was new in aggressive non-Hodgkin lymphoma at this year's American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) virtual meetings?
This interview outlines three main fields of development:
What was new in aggressive NHL at ASCO and EHA 2020?
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Your opinion matters
Practice-changing abstracts in indolent lymphoma at EHA 2020
Interview with Martin Dreyling outlining the practice-changing abstracts in indolent lymphoma from EHA 2020.
EHA 2019 | How will the sequencing of treatments for DLBCL change in the future?
Ulrich Jäger from the Medical University of Vienna, Vienna, AT, discusses how to decide what treatments to use, and when, for patients with relapsed/refractory (R/R)...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox